LaGray Chemical Company is the first fully-integrated generic pharmaceutical manufacturing facility in West Africa, producing both active pharmaceutical ingredients as well as finished dosage forms.


Our focus is on pharmaceuticals for the treatment of a wide variety of diseases such as HIV-AIDS and opportunistic infections, malaria, tuberculosis, parasitic, bacterial and fungal infections, as well as hypertension. These are diseases are endemic in West Africa and major contributors to mortality and morbidity in the region.


LaGray is pioneering the push toward self-sufficiency in healthcare in sub-Saharan Africa.